Off-label Use of Recombinant Activated Factor VII for Cardiac Surgical Bleeding

被引：5
作者：
Flynn, Brigid C. [1 ,4 ]
Steiner, Marie E. [2 ]
Mazzeffi, Michael [3 ]
机构：
[1] Univ Kansas, Dept Anesthesiol, Med Ctr, Kansas City, KS USA
[2] Univ Minnesota, Div Hematol Oncol & Crit Care, Minneapolis, MN USA
[3] Univ Virginia, Dept Anesthesiol, Sch Med, Charlottesville, VA USA
[4] Univ Kansas, Dept Anesthesiol, Med Ctr, Kansas City, KS 66160 USA
来源：
ANESTHESIOLOGY | 2023年 / 139卷 / 02期
关键词：
BLOOD-CELL TRANSFUSIONS; ACUTE AORTIC DISSECTION; INTRAOPERATIVE USE; DOUBLE-BLIND; SURGERY; SAFETY; NOVOSEVEN(R); MANAGEMENT; EFFICACY; RFVIIA;
D O I：
10.1097/ALN.0000000000004569
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
This review discusses the history and present-day off-label use of recombinant activated factor VII for cardiac surgical bleeding.
引用
收藏
页码：197 / 210
页数：14
相关论文
共 68 条
[1]  
Abdel-Meguid Mohamed Essam, 2013, Saudi J Anaesth, V7, P301, DOI 10.4103/1658-354X.115364
[2]   Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery [J].
Al Douri, M ;
Shafi, T ;
Al Khudairi, D ;
Al Bokhari, E ;
Black, L ;
Akinwale, N ;
Musa, MO ;
Al Homaidhi, A ;
Al Fagih, M ;
Andreasen, RB .
BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 :S121-S127
[3]   Recombinant Factor VII Is Associated With Worse Survival in Complex Cardiac Surgical Patients [J].
Alfirevic, Andrej ;
Duncan, Andra ;
You, Jing ;
Lober, Cheryl ;
Soltesz, Edward .
ANNALS OF THORACIC SURGERY, 2014, 98 (02) :618-624
[4]   Thrombin generation by activated factor VII on platelet activated by different agonists. Extending the cell-based model of hemostasis [J].
Altman R. ;
Scazziota A.S. ;
Herrera M. de L. ;
Gonzalez C. .
Thrombosis Journal, 4 (1)
[5]   Intraoperative Use of Low-Dose Recombinant Activated Factor VII During Thoracic Aortic Operations [J].
Andersen, Nicholas D. ;
Bhattacharya, Syamal D. ;
Williams, Judson B. ;
Fosbol, Emil L. ;
Lockhart, Evelyn L. ;
Patel, Mayur B. ;
Gaca, Jeffrey G. ;
Welsby, Ian J. ;
Hughes, G. Chad .
ANNALS OF THORACIC SURGERY, 2012, 93 (06) :1921-1929
[6]   Safety of recombinant factor VIIa in patients under extracorporeal membrane oxygenation [J].
Anselmi, Amedeo ;
Guinet, Patrick ;
Ruggieri, Vito Giovanni ;
Aymami, Marie ;
Lelong, Bernard ;
Granry, Solene ;
Malledant, Yannick ;
Le Tulzo, Yves ;
Gueret, Pierre ;
Verhoye, Jean-Philippe ;
Flecher, Erwan .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2016, 49 (01) :78-84
[7]   Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis [J].
Bernardi, Francesco ;
Mariani, Guglielmo .
HAEMATOLOGICA, 2021, 106 (02) :351-362
[8]   Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications [J].
Bhaskar, Balu ;
Zeigenfuss, Marc ;
Choudhary, Jivesh ;
Fraser, John F. .
TRANSFUSION, 2013, 53 (04) :798-804
[9]   Analysis of Outcomes Using Low-Dose and Early Administration of Recombinant Activated Factor VII in Cardiac Surgery [J].
Brase, Jason ;
Finger, Brooke ;
He, Jianghua ;
Wirtz, Katy ;
Stun, Lucy ;
McMillen, Randy ;
Flynn, Brigid .
ANNALS OF THORACIC SURGERY, 2016, 102 (01) :35-40
[10]   High Incidence of Thromboembolic Events in Left Ventricular Assist Device Patients Treated With Recombinant Activated Factor VII [J].
Bruckner, Brian A. ;
DiBardino, Daniel J. ;
Ning, Qian ;
Adeboygeun, Alfred ;
Mahmoud, Karim ;
Valdes, Jamie ;
Eze, John ;
Allison, Paul M. ;
Cooley, Denton A. ;
Gregoric, Igor D. ;
Frazier, Oscar H. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (08) :785-790
1234567